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Open access under CC BY license.Centriole: a multiprotein barrel-like microtubule-based structure at the core of
the centrosome responsible for recruiting PCM proteins.
Cerebral cortex: also called the ‘grey matter’ the structure in the brain
responsible for most information processing.
Cleavage plane: the axis along which cell division occurs.
Cohort: a group of humans with a shared diagnosis gathered and studied
together to identify common features of a particular phenotype.
Consanguineous families: families in which marriages between family
members (e.g. cousins) have occurred.
Hh/Shh signalling: ‘Hedgehog’ or ‘Sonic Hedgehog’ signalling pathways are
involved in regulating development in several tissues.
Holoprosencephaly: a failure of the forebrain to divide to form the two cerebral
hemispheres during development. Depending on the severity, this can lead to
malformations of the brain and facial features, seizures and mental retardation.
In very severe cases, the fetus might miscarry.
ImmunoEM: electron microscopy using antibodies conjugated to gold
nanoparticles.
Locus/loci: a region in the genome that is shared by all individuals affected by
a particular phenotype.
Microcephaly: the finding that an individual’s head circumference is signifi-
cantly below the expected mean for age and sex. The measurement must be
made from the back of the head across the brow and should be the largest
measurement possible. As it is the brain that pushes out on the skull and drives
skull bone growth, a symmetrical microcephaly indicates a brain that is of
reduced size. If the skull is asymmetric, then this usually indicates a
craniosynostosis, a defect of skull bone growth and union.
Primary microcephaly: a form of microcephaly present at birth, that is not due
to other pathological defects such as maternal alcoholism, diabetes or rubella.
Missense mutation: a pathogenic mutation in DNA resulting in a changed
amino acid in the protein.
Neuroepithelium: the first structure formed during cortical neurogenesis.
Neurogenesis: although this term can be used to mean different aspects of
brain development, for the purpose of this article, it refers specifically to the
process by which neurons are generated during embryonic development.
Neurosphere: a culture derived from mouse embryonic stem cells that have
formed a heterogeneous mass of cells at varying stages of differentiation along
a neural lineage.
Non-synonymous SNP: a ‘single nucleotide polymorphism’ that causes a
change in the amino acid encoded by the triplet that it lies within.
Pericentriolar matrix (PCM): the complex of proteins recruited to and
surrounding the centrioles. Many appear to influence microtubule dynamics
and other centrosome functions.
Pial surface: the pia is the outermost membrane surrounding the developing
brain.
Progenitor: a cell that has some characteristics of a stem cell (i.e. it can self
renew) but that has become restricted to producing differentiated cells of a
particular lineage, for example neuronal cells.
Proteasome: a large protein multisubunit complex found in the cytoplasm thatThe relatively large brain and expanded cerebral cortex
of humans is unusual in the animal kingdom and is
thought to have promoted our adaptability and success
as a species. One approach for investigating neurogen-
esis is the study of autosomal recessive primary micro-
cephaly (MCPH), in which prenatal brain growth is
significantly reduced without an effect on brain struc-
ture. To date, eight MCPH loci and five genes have been
identified. Unexpectedly, all MCPH proteins are ubiqui-
tous and localise to centrosomes for at least part of the
cell cycle. Here, we focus on recent functional studies of
MCPH proteins that reveal the centrosome as a final
integration point for many regulatory pathways affect-
ing prenatal neurogenesis in mammals.
The genetics of MCPH
The initial definition of autosomal recessive primary
microcephaly (MCPH; see Glossary) has proved useful to
both clinicians and researchers: an individual with a small
but structurally normal brain, a mild-to-moderate mental
retardation but otherwise normal in appearance, health
and neurological functioning [1,2]. As such, MCPH can be
considered a ‘model’ disease to find genes that have essen-
tial and non-redundant functions in prenatal neurogen-
esis. The incidence is 1 in 10 000 in consanguineous
populations, less in non-consanguineous populations.
The cerebral cortex is particularly reduced in size in this
disorder, leading to an apparently ‘simplified gyral pattern’
as mantle thickness is preserved but surface area is
reduced [3,4]. Magnetic resonance imaging studies of an
affected family having prenatal diagnosis have shown the
frontal lobes of the cerebral cortex to be particularly
affected [4,5].
There are at least eight MCPH loci, and the genes
underlying five of these have been identified (Table 1).
The most recent MCPH gene to be identified was theGlossary
Astral microtubules: the microtubule array nucleated by the centrosome
during mitosis. Astral microtubules extend from the spindle poles to contact
the cell cortex and function in spindle positioning.
BRCT domain: named after the protein first shown to contain this domain; it is
found in proteins involved in DNA damage repair.
Centrosome: a complex multiprotein structure comprised of two centrioles
surrounded by an electron-dense amorphous material, the PCM. An
important regulator of many functions and the predominant site of
microtubule assembly within a cell. Centrosomes co-localise with the spindle
poles during mitosis.
is responsible for the degradation of proteins to regulate their levels or to
remove misfolded proteins that might be damaging to the cell. Recognition of
targets for degradation is achieved through addition of many copies of a small
molecule ‘tag’ called ubiquitin.
Radiomimetic: a drug, the effects of which mimic irradiation when applied to
cells.
Spindle poles: where spindle microtubules converge at the two ends of the
mitotic spindle. In somatic cells, the two poles of the bipolar spindle structure
each contain a centrosome. The centrosomes produce astral microtubules that
contact the cell cortex and are thought to provide spatial information and
contribute tensile forces for chromatid separation.
Somite: ‘blocks’ of mesoderm that form sequentially either side of the extending
neural tube as a mammalian embryo develops and that will later develop into
skin, vertebrae and skeletal muscle. Often used by researchers instead of age to
determine more precisely the exact developmental stage of an embryo (as
environmental factors can influence the rate of developmental progression).
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Table 1. MCPH genes, proteins, localisations and functionsa
Locus Chromosome
location
Gene Protein Cellular localisation Function
MCPH1 8p23 MCPH1/MICROCEPHALIN/BRIT1
(BRCT inhibitor of telomerase I)
Microcephalin/BRIT1 Nucleus/chromatin;
centrosome
DNA damage repair;
chromosome condensation;
transcriptional regulation
of DNA damage genes
MCPH2 19q13.12–q13.2 Not identified Unknown Not known Unknown
MCPH3 9q33.2 CDK5RAP2/CEP215
(centrosomal protein 215)
CDK5RAP2/Cep215 Centrosome throughout
cell cycle; midbody
at cytokinesis
Predicted role in regulating
microtubule dynamics; PCM
recruitment and stabilisation;
centrosome maturation
and cohesion
MCPH4 15q15–q21 Not identified Unknown Not known Unknown
MCPH5 1q31.3 ASPM ASPM Pericentrosomal
at mitotic spindle poles;
midbody at cytokinesis;
cytoplasmic at interphase
Spindle pole organisation
and orientation
MCPH6 13q12.12 CENPJ/CPAP (centrosome
protein 4.1 associated protein)
CENPJ/CPAP Centrosome throughout
cell cycle; midbody
at cytokinesis
Centriole biogenesis and
length; microtubule
dynamics
MCPH7 1p33 STIL/SIL SIL/STIL Pericentrosomal at mitotic
spindle poles
Spindle organisation;
Hh/Shh signalling
aThe HGNC name is highlighted in bold for each gene, although the most common alternatives are also given.
Review Trends in Genetics Vol.25 No.11MCPH7 gene SIL/STIL, from four consanguineous Indian
families [6]. Mutations in SIL are a rare cause of MCPH, as
are mutations in the genes encoding cyclin-dependent
kinase 5 regulatory associated protein 2 (CDK5RAP2)
and centromere protein J (CENPJ), as no further cases
were found in a cohort of 100 Pakistani MCPH families [6].
Mutations in the abnormal spindle-like microcephaly
associated gene (ASPM) cause 50% of MCPH, irrespective
of ethnic background [2,7–9], whereas MCPH2 mutations
account for 10% of cases. Although the MCPH2 locus was
discovered in 1999, the gene has eluded discovery so far
despite extensive sequencing of the locus, suggesting that
the mutational mechanism is unusual and not detectable
by conventional exonic sequencing. A third of MCPH cases
have not been linked to known loci, so further genes await
discovery. All the MCPH proteins identified are ubiqui-
tously expressed and have a centrosomal association for at
least part of the cell cycle; suggesting knowledge of aBox 1. MCPH, evolution and the link with Homo floresiensis
There has been a clear increase in relative brain size from monkeys to
apes to humans. In just 3–5 million years the human brain increased
threefold in size compared with that of our closest primate relatives.
This has led to a search for the genes (and the changes within those
genes) responsible for this expansion. The MCPH genes were obvious
candidates as mutations affect brain size exclusively, and evidence of
positive Darwinian selection was found in the monkey–primate–
human evolutionary tree for MCPH1, 3, 5 and 6 [1,57]. This evidence
was gathered by comparing the rate of DNA base changes that do not
affect protein sequence (synonymous) with those that do change an
amino acid (non-synonymous) both within and between species over
a defined time period. Non-synonymous changes can alter protein
function. This alteration can be beneficial and subsequently either
‘selected for’, neutral, or deleterious and ‘selected against’.
Taking this approach further, when whole brain, cerebellum and
cerebral cortex were analysed separately in primates, ASPM positive
selection correlated only with cerebral cortex size, and appeared to be
due to changes in only 16 out of the 3477 amino acids constituting
ASPM [58]. Controversially, it was claimed that ASPM and MCPH1
were still undergoing evolutionary change in modern humans [59–
62]. Remarkably, the ‘selected’ changes were not altering either brain
502centrosomal association might provide guidance in the
selection of candidate genes.
Almost all mutations that cause MCPH introduce a
premature stop codon, predicted to cause nonsense-
mediated decay [2,9]. Whether these lead to functional
nulls (no protein produced), or a significant reduction in
protein levels is as yet undetermined. However, two mis-
sense mutations have been reported; one in CENPJ and
one in ASPM, but their clinical significance remains
unclear in lieu of functional studies [7]. This is particularly
important when interpreting ASPM mutations as it is a
large gene containing many, often rare, non-synonymous
SNPs [2]. Therefore, any missense mutation in ASPM
should be regarded as non-pathogenic until proven other-
wise [2].
Microcephalic osteodysplastic primordial dwarfism -
type Majewski II (MOPD-II) has an interesting phenotypic
overlap with MCPH and Seckel syndrome. A disordersize or intelligence and it was hypothesized that sperm number or
function was instead being affected (although ASPM MCPH males
have fathered children). However, other groups have disputed the
validity of these findings, as they could not be replicated, instead
suggesting that the high variability observed in ASPM renders such
analysis inaccurate [63,64]. Another study claimed that a MCPH1
haplotype, present in 70% of modern humans, originated from
another hominid species [65]. Such nucleotide-based analyses of
MCPH are highly complex, however, and await careful validation by
functional studies.
Finally, the remains of a dwarfed microcephalic hominid found on
the Flores Islands, Homo floresiensis, was speculated to be a case of
either MOPD-II or MCPH [11,66] rather than a new hominid species.
Further analysis has now supported the original theory that H.
floresiensis was a separate hominid species that did exist, but became
extinct [67]. Despite the need for functional analyses of these
changes, these reports provide exciting speculations about the
development of humans as a species. As the Neanderthal genome
nears completion, all the DNA changes separating modern humans
from their closest hominid relative, who became extinct 30 000 years
ago, will soon be known [68].
Box 2. Are MCPH proteins implicated in other diseases?
As the MCPH proteins act in pathways affecting cell-cycle progres-
sion, proliferation and genome integrity, are there any indications of a
contribution to pathogenesis in other diseases, such as cancer?
Downregulation of ASPM expression resulting in delayed mitotic
exit was observed upon expression of a Hepatitis C virus protein that
reduces p38 MAPK activation [69]. It would be interesting to
investigate whether ASPM expression status changes during sub-
sequent tumourigenic transformation, as ASPM mRNA upregulation
is correlated with disease progression and poor clinical outcome in
both glioblastoma and primary hepatocellular carcinoma
[29,30,70,71]. Additionally, ASPM was one of eight genes strongly
upregulated in immortalised cells and cancer cells (although not in
neuroblastoma) [72].
Similarly, SIL mRNA is expressed in many tumours (except
glioblastoma) and malignant cell lines from diverse tissues. Expres-
sion increases upon DNA synthesis induction; conversely, terminal
differentiation or growth arrest leads to downregulation [51,73]. SIL
relieves Gli1 inhibition through an interaction with suppressor of
fused homolog (SUFU), and so promotes the transcription of target
genes, including those encoding cyclin D1 and Patched; this
interaction was enhanced by oncogenic K-Ras expression [74].
Conversely, inducing SIL knockdown in a cancer cell line resulted
in a G2/M growth arrest owing to delayed Cdk1 activation and
increased apoptosis, suggesting that SIL is a potential therapeutic
target [50].
As for CENPJ, its expression has been detected in breast cancer cell
lines [1], although there are no recent studies building on this finding;
and CDK5RAP2 downregulation has been recently linked to doxor-
ubicin and paclitaxel resistance, commonly used in combination
therapy for advanced breast cancer, suggesting that CDK5RAP2 could
provide a pathway for tumour cells to evade destruction [75].
In contrast to the other MCPH genes, MCPH1 expression is
downregulated in breast cancer cell lines, ovarian and prostate
tumours, and is linked to increased genomic instability. Conse-
quently, MCPH1 has been proposed as a potential tumour
suppressor [1].
What about patients with MCPH? Owing to practical difficulties,
there has been little formal analysis of disease occurrence in such
patients; however, anecdotal evidence suggests that the incidence of
cancer is low, and possibly less than in the general population.
Patients with MCPH do not appear to suffer from defective immune
responses (centrosomes are involved in T-cell activation) or gut
problems (a tissue that is dependent on maintaining stem cell
divisions throughout life). However, although data are limited and
based mainly on cell assays or mouse models, the current findings
are interesting.
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ture, primary microcephaly and a distinctive facies associ-
ated with severe developmental delay. MOPD-II results in
a marked microcephaly of similar severity to MCPH but
with proportionate short stature, which is not seen in
MCPH (there is some speculation that Homo floresiensis
is a case of MOPD-II; Box 1). In further contrast to MCPH,
individuals affected with MOPD-II have cognitive abilities
within the normal range. The MOPD-II gene has recently
been identified as pericentrin (PCNT) [10–12], which
encodes a key centrosomal protein, a further indicator that
centrosomal proteins and/or centrosomes act as key organ-
isers of early neurogenesis.
What do MCPH proteins do?
Recent studies of the functions of MCPH proteins have
produced some interesting results. Whereas previous stu-
dies indicating roles for ASPM in spindle organisation,
CDK5RAP2 and CENPJ in transcriptional regulation and
microtubule dynamics, or MCPH1 in DNA damage have
been expanded upon, new roles and connections have been
uncovered. Recent reports may begin to explain how these
proteins influence neurogenesis, including a possible func-
tional relationship between PCNT and MCPH1, and there
is evidence to suggest that MCPH proteins have a role in
the progression of other diseases (Box 2).
MCPH1: a protein of two halves
The loss ofMCPH1 in experimental systems including fruit
flies (Drosophila melanogaster), chicken cell lines or
human patient cell lines, results in a range of phenotypes,
including reduced protein recruitment to centrosomes,
formation of abnormal spindles, missegregation of DNA,
aberrant cytokinesis, changes in cell-cycle progression and
defects in DNA damage repair [13–25]. But how are these
phenotypes interconnected? Does MCPH1 have one or
many roles?What is the contribution of the three BRCA1 C
Terminal (BRCT) domains of MCPH1? Recent researchhas contributed further understanding of the multiple
pathways and processes requiring MCPH1.
MCPH1 contains three BRCT domains (BRCT1–3),
which control various aspects of its function. Current
research suggests the N-terminal BRCT domain (BRCT1)
of MCPH1 predominantly regulates its centrosome and
cell-cycle regulatory functions. In chicken DT-40 cells,
MCPH1 localisation at the centrosome after irradiation
requires BRCT1, independent of DNA damage signalling
pathways. Centrosomal localisation persists in the absence
of DNA damage throughout the cell cycle, although this is
not completely dependent on BRCT1 [17].
A study of patient lymphoblastoid cells found that cen-
trosomal localisation of PCNT is reduced if MCPH1 is lost,
whereas loss of either protein reduces recruitment of g-
tubulin. MCPH1 and PCNT together recruit Chk1 kinase
to the centrosome and, thus, are required for maintaining
the inhibitory phosphorylations of Cdk1 kinase on Tyro-
sine15 and Cdc25B phosphatase on Serine230, which
together prevent mitotic entry. Loss of MCPH1 reduces
inhibition, promoting a premature entry into mitosis,
which is manifested as premature chromosome conden-
sation (PCC) [22,25]. Reduced phosphorylation of Tyro-
sine15 of Cdk1 was also seen in one study of Drosophila
melanogaster mcph1 mutants [13]. This might explain
why, although MCPH1 and Condensin II directly interact,
expression of the interacting region alone could not reverse
PCC, whereas expression of BRCT1 could [16]. Therefore,
the loss of mitotic entry inhibition might provide the signal
prematurely activating Condensin II and promoting PCC,
rather than the loss of MCPH1 and Condensin II associ-
ation. The requirement for both MCPH1 and PCNT for
proper Chk1 recruitment might explain the similarities
observed between MCPH and MOPD-II phenotypes
[11,12,22].
The C-terminal domains, BRCT2 and 3, largely coordi-
nate the DNA damage response, and it appears that
MCPH1 is involved at multiple stages in response to a503
Box 3. Mammalian neurogenesis: the basics
Mammalian neurogenesis is best characterised in mouse, so we will
focus on this model here. The first progenitor cells in the developing
brain are the apical NE progenitor cells. These are attached to the apical
and pial surfaces, polarised along the apico-basal axis and form
adherens junctions, which are essential for the maintenance of polarity.
NE cells adopt a ‘pseudostratified’ appearance, owing to migration
of the nucleus between the ventricular (apical) surface and more basal
positions (Figure Ia,b). S-phase DNA replication occurs as the nucleus
reaches its most basal position (Figure Ia, iii), before returning to the
apical surface to undergo mitosis. Strikingly, the centrosomes remain
at the apical membrane during G1, S- and G2 phases, leading to the
appearance of a ‘line’ of interphase centrosomes upon immunofluor-
escence imaging (Figure Ic).
The apical membrane of each NE cell encompasses a tiny but
crucial fraction of the whole cellular membrane and expresses several
apical proteins. Early in neurogenesis, NE cells predominantly
complete cytokinesis, bisecting the apical plasma membrane. Both
daughter cells receive apical membrane proteins, remain attached to
their neighbours and adopt a NE cell fate. This is called a symmetrical
proliferative division (Figure Ia,v, vi).
As neurogenesis progresses, progenitor divisions begin to deviate,
leading to bypass of the apical membrane. This results in an
asymmetrical neurogenic division (Figure Ia, vii–ix). Only one daughter
receives an apical membrane and adherens junctions and remains a NE
cell. The other detaches from the ventricular surface (which can take
several hours) and migrates sub-ventricularly, becoming either a basal
progenitor or a neuron (Figure Ia viii, ix, Figure Ib).
In contrast to NE progenitors, basal progenitors are not connected to
either apical or pial surfaces and are unpolarised. These progenitors
predominantly divide terminally in a symmetric neurogenic manner to
produce two neurons (Figure Ia, ix, x), although a sub-population can
undergo limited rounds of self expansion. The number of rounds of
symmetric proliferative divisions by NE cells is thought to be crucial for
the eventual numbers of neurons. A single progenitor undergoing ten
rounds of asymmetric division will produce ten neurons; by contrast, if
all but the last division is symmetric, 512 neurons can be produced.
In higher primates and humans, other progenitor populations exist
that provide possibilities for a prolonged expansion phase. These are
covered in detail elsewhere [76,77]. For a detailed exposition of
neurogenesis, evolution and morphology, see Ref. [76].
Figure I. The developing mouse neuroepithelium. (a) The neuroepithelium and the process of cell division. Neuroepithelial cells (blue) have processes contacting the apical
(ventricular) and pial (basal) surfaces. The nuclei in dark blue migrate basally during G1, cells (i,ii) undergo S phase at a basal position (iii); and migrate again apically during
G2 (iv). The centrosomes (red circles) remain by the apical membrane (green). Mitosis occurs at the apical surface, where the centrosomes now form the spindle poles.
Symmetrical division leads to the production of two identical neuroepithelial cells (v,vi). By contrast, asymmetrical division (vii) leads to production of one neuroepithelial
cell, whereas the other daughter detaches from the membrane (viii) and becomes either a basal progenitor (ix) or a neuron. Basal progenitors (ix) lack processes and polarity
and predominantly divide terminally to produce two neurons (x). (b) Immunofluorescence in E14 mouse neuroepithelium showing the apical progenitors and their processes
(nestin, green), basal progenitors (Tbr2, red) and neurons (bIII Tubulin, purple). (c) Immunofluorescence in E12 mouse neuroepithelium showing the apical progenitors and
their processes (nestin, green), the nuclei of the apical progenitors (DAPI, blue) and the centrosomes (g-tubulin, white). Note the arrow pointing to the cell in metaphase.
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Review Trends in Genetics Vol.25 No.11range of DNA-damaging insults [15,17]. MCPH1 recruit-
ment to DNA damage foci is rapid and depends on BRCT2
and 3 binding specifically to phosphorylated gH2AX, the
first protein recruited [15]. MCPH1 recruitment precedes
other DNA-damage mediators; lying upstream in both
ataxia telangiectasia mutated/ ATM and Rad3-related
(ATM/ATR) pathways, it is required for the recruitment
of Rad51, BRCA2, 53BP1, mediator of DNA-damage check-
point 1 (MDC1), phospho-ATM, phospho-NBS1, replication
protein A (RPA) and Rad17 [15,16,18,23]. Similarly,
MCPH1 is recruited to telomeres, where it regulates the
response to DNA damage and telomere dysfunction foci
formation [21].
There is evidence to suggest that MCPH1 also regulates
the transcription of DNA-damage genes. An interaction
between MCPH1 and the E2F transcription factor 1
(E2F1) in unstimulated cells is enhanced after application
of a radiomimetic drug. Binding required the BRCT2 and 3
domains of MCPH1; and MCPH1 and E2F1 were shown to
co-occupy the promotors of BRCA2, CHK1, p73 and cas-
pase7. The expressionofDNAdamage response genes topoi-
somerase (DNA) IIbindingprotein1 (TOPBP1),RAD51, and
damage-specific DNA binding protein 2 (DDB2) was also
found to be MCPH1 dependent, suggesting that a subset of
E2F1 targets that are important for apoptosis are also de-
pendent on MCPH1 regulation [20]. Finally, BRCT1 also
contributes to DNA-damage repair, as it is required to
interact with the switch/sucrose nonfermentable (SWI–
SNF) chromatin remodelling complex and thereby regulate
chromatin relaxation. This change in chromatin confor-
mation facilitates access of DNA-damage repair proteins
modulating repair efficiency and cell survival [24].
The functions of MCPH1 can therefore be subdivided
into cell cycle and/or centrosome effects mediated by the N-
terminal BRCT1 domain, and regulation of DNA-repair
efficiency predominantly mediated through BRCT2 and
BRCT3. Which of these functions is key for neurogenesis
has yet to be determined, because both cell-cycle length
and defective DNA damage responses have been shown to
affect neurogenesis [26].
ASPM: spindle organiser and rotational regulator
ASPM is the only MCPH protein for which a role in
neurogenesis has been directly assessed. Aspm mRNA is
expressed in the ventricular zone (VZ) of mouse neuroe-
pithelium, particularly in progenitors undergoing prolif-
erative divisions. Expression is high at the onset of
neurogenesis and during the early stages, decreasing pro-
gressively as neurogenesis proceeds. Aspm protein loca-
lises to mitotic spindle poles with, but not overlapping, g-
tubulin, consistent with previous data [1,27]. A mouse
knock-in line where GFP is expressed only in neurogenic
progenitors demonstrated that levels of Aspm were
reduced in neurogenic compared with proliferative pro-
genitors.
However, RNAi knockdown of Aspm in the neuroepithe-
lium did not affect cell-cycle progression or block mitosis,
and centrosome detachment only occurred during telo-
phase. Instead, loss of Aspm resulted in an increased
deviation of the cleavage plane in proliferative neuroe-
pithelial progenitors, causing almost 50% of them tobypass the apical membrane and resulting in unequal
inheritance of this domain by the daughter cells (Box 3).
As a result of this bypass, an increase in neuron-like
progeny was observed. This suggests that loss of Aspm
disrupts cleavage plane alignment, causing an increase in
non-neuroepithelial progeny and depleting the progenitor
pool prematurely [27].
Interestingly, the nematode Caenorhabditis elegans
orthologue ASPM-1 has a similar role regulating meiotic
spindle rotation, but is dispensable during early mitotic
divisions in contrast to other organisms. Calmodulin
(CMD-1) recruits ASPM-1, and together they recruit
LIN-5, forming a complex at meiotic and mitotic spindle
poles. RNAi knockdown of either aspm-1 or cmd-1 caused
defects in meiosis I and II, affecting the coordination of
chromosome segregation and spindle positioning. Spindle
repositioning to the cell cortex was independent of the
ASPM-1–CMD-1–LIN-5 complex. Once repositioned, the
spindle normally rotates by 90o; however, rotation was
defective in aspm-1, cmd-1 or lin-5 knockdowns. Further
experiments suggest LIN-5–ASPM-1–CMD-1 regulates
spindle positioning through dynein recruitment. However,
disorganised spindles with unfocused spindle poles were
observed only after aspm-1 depletion, suggesting that
ASPM-1 alone is required for spindle organisation [28].
In general, ASPM expression has been linked to pro-
liferation and is highest in progenitor cells. Mouse Aspm is
downregulated upon neurosphere differentiation, and
knockdown ofAspm reduced both the self-renewal capacity
and proliferation of neurospheres upon re-culture. This
suggests that ASPM is important for maintaining the
proliferative capacity of progenitors [29]. In agreement
with this, ASPM expression is high in fetal tissues and
cancer cell lines, but low in adult tissues [30]. ASPMmight
also contribute to adult neurogenesis, as stimulating pro-
liferation of neural precursors in adult rat hippocampus
induced Aspm expression [31].
ASPM is therefore highly expressed in progenitor cells
and regulates spindle organisation and positioning. In
mouse neurogenesis, this appears to be directly linked to
fate determination for neuroepithelial (NE) progenitors,
and a similar premature depletion of the progenitor pool
could explain the reduced numbers of neurons in patients
with MCPH.
CENPJ: how does your centriole grow?
CENPJ, also known as CPAP, is a centriolar protein. Loss
of the CENPJ orthologue dSAS-4 in Drosophila leads to
the loss of centrioles; although knockout flies survive until
adulthood, their coordination is poor and viability is also
low [32]. Further study of a sas4 knockout mutant and a
dominant negative demonstrated a requirement for dSas-4
in spermatogenesis, where loss of centrioles results in
abnormal spindle formation and DNA segregation defects
[33]. A similar requirement for dSas-4 in early embryogen-
esis has also been demonstrated [34].
Dynamic studies of SAS-4 in C. elegans have also been
informative in delineating function in centriole biogenesis.
A SAS-4::GFP fusion protein was found to localise to cen-
trioles in S phase and weakly to the surrounding pericen-
triolar matrix (PCM; Figure 1), although PCM recruitment505
Figure 1. The structure of the centrosome. The centrosome is a large complex
structure. At its centre sit two centrioles, which are orientated perpendicularly to
each other and are linked (orange lines). One centriole, termed the ‘mother’
centriole, is older and fully mature, whereas the other is called the ‘daughter’
centriole. The mother can be distinguished from the daughter by the presence of
the sub-distal appendages (purple). Each centriole takes 1.5 cell cycles to reach
maturation. The centrioles are barrel-like in appearance and are surrounded by a
ninefold symmetrical arrangement of triplet microtubules (orange rods). The
centriole pair accumulate numerous other proteins to form the PCM. The
centrosome is one of the main microtubule organising centres in the cell, and is
also implicated in coordinating many pathways.
Review Trends in Genetics Vol.25 No.11increased in late prophase, giving a biphasic appearance
to SAS-4 dynamics. Centriolar recruitmentwas coincident
with SAS-6 rather than following it, as had been suggested
in previous studies based on analysing fixed cells [35]. A
dynamic equilibrium exchanging SAS-4 between the cyto-
plasmic pool and the centriole and/or PCM was observed
that persisted until the recruitment of microtubules to the
centriole at late prophase, whereupon SAS-4 incorpora-
tion appeared to be stabilised. This PCM recruitment and
subsequent stabilisation required g-tubulin and microtu-
bules [36].
What is the function of CENPJ in human cells? Previous
work had identified both a microtubule-binding domain
(MBD) and a microtubule-destabilising domain (MDD)
within CENPJ [37]. The MDD region has been refined to
aa311-422 [38,39] and is conserved in Drosophila dSAS-4.
It was shown that theMDD domain binds to tubulin with a
stoichiometry of 1:1 sequestering it in an unpolymerisable
complex, and forming a tight association that interferes
with the longitudinal intermolecular interactions of b-
tubulin [39].
How is this role in microtubule dynamics related to
cellular function? CENPJ is one of four highly conserved
proteins required for centriole biogenesis (Figure 2). Two
studies of overexpression of CENPJ showed formation of
elongated ‘threads’ beginning at S-phase, which rapidly
elongated during the G2 and M phases. The threads con-
tained acetylated tubulin and polyglutamylated tubulin506(both indicative of stabilised microtubules), and centriolar
proteins, including Cep135, centrins and centrobin [40,41].
Threads occurred at both the centriole and procentriole;
and although proximal centriolar structures appeared
normal, the distal ends were distorted, with incomplete
microtubule formation and randompositioning of subdistal
appendages. Despite this, they could recruit PCM, result-
ing in formation of extra procentrioles, increased multi-
polar spindle formation and defective mitoses.
Interestingly, both studies also identified Cep110 as an
antagonistic partner to CENPJ in regulating centriole
length [40,41]. One group also observed a proteasome-
mediated cell-cycle-dependent downregulation of CENPJ
levels at the end of mitosis and start of G1 and identified
the elements in CENPJ required for recognition by the
APC/CCdh1 degradation complex [41].
CENPJ is therefore a crucial regulator of centriole
length during centriole biogenesis, possibly functioning
in the correct recruitment of centriolar microtubules. Pro-
teasomal degradation prevents excess accumulation in the
next cell cycle promoting formation of extra centrosomes.
Loss of centrioles results in deformed spindles and DNA
segregation defects. Loss of CENPJ could result in an
MCPH phenotype through lack of mature centrosomes,
as astral microtubules would not be generated properly
and spindle positioning impaired. This might lead to devi-
ations in cleavage plane alignment similar to ASPM; how-
ever, this hypothesis needs confirmation in experimental
systems.
CDK5RAP2: the centrosome tether and PCM builder
CDK5RAP2, also known as Cep215, was previously
reported to associate with the g- tubulin ring complex (g
-TURC), involved in nucleating microtubules at the cen-
trosome. A recent study has now shown a direct interaction
between CDK5RAP2 and g-TURC components. Overex-
pression of the g-TURCbinding region of CDK5RAP2 acted
as a dominant negative, sequestering g-tubulin and lead-
ing to unfocused interphase microtubules lacking a normal
radial array pattern; in mitotic cells, spindle poles had
fewer astral microtubules and reduced g-tubulin accumu-
lation. Despite this, mitosis and spindle checkpoints
appeared to be unaffected [42]. Overexpression of full-
length CDK5RAP2 caused protein aggregates to form both
at the centrosomes and in the cytoplasm. These also accu-
mulated increased PCNT, g-tubulin, Cep250 and tubulins,
and could nucleate microtubules without centrioles.
CDK5RAP2 is centrosomal throughout the cell cycle,
and immunoEM showed localisation to the PCM adhering
to the centrioles and centriolar appendages [42].
An siRNA screen identified CDK5RAP2 as one of a few
proteins required for centrosome cohesion [43]. Knockdown
of CDK5RAP2 led to centrosome splitting, and reduced
PCNT localisation at the centrosome, although other
proteins tested localised normally. CDK5RAP2 localis-
ation to the centrosome is also partially dependent on
PCNT [43,44]. Interestingly, another group found that a
mitosis-specific increase in both CDK5RAP2 and PCNT
(along with Cep192) localisation to the centrosome was
abrogated when Plk1 (polo like kinase 1) was inhibited
[44].
Figure 2. The centrosome division cycle. Centrosome duplication and maturation are linked to cell-cycle progression. In early G1, post division, the cell contains one
centriole pair consisting of a mature mother centriole, which has sub-distal appendages, and an immature daughter centriole, connected to each other by a linker. During
G1, pro-centrioles form perpendicularly to both the mother and daughter centrioles and continue to lengthen as G1 progresses. Around S-phase, the original daughter
centriole reaches maturation, acquiring sub-distal appendages, and the link between the original centriole pair is broken. PCM proteins begin to accumulate during centriole
duplication, forming two centrosomes each containing a centriole pair. This accumulation continues through the G2 phase as centrosomes mature. The final steps in
maturation are the addition of centriolar microtubules around late prophase. The centrosomes, which until now have remained associated with each other, separate and
move to opposing sides of the nucleus. During mitosis a bipolar spindle forms to ensure faithful DNA segregation and, at each end, there is a spindle pole each containing a
centrosome. The centrosome is responsible for generating the astral microtubule array, which enables correct spindle orientation to occur. Upon cytokinesis, each daughter
cell inherits a single centriole pair and the cycle begins again.
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of CDK5RAP2, suggest that it is required for centrioles to
maintain a stable connection both to accumulated PCM
during centrosome maturation, and to astral microtubule
arraysgeneratedby the centrosomeduringmitosis.Without
cnn, centrioles become displaced to the PCM periphery
before losing contact and migrating randomly in the cyto-
plasm [45]. A screen for proteins involved in centriole dupli-
cation and centrosome maturation (Figure 2) found that
disruption of cnnorP could completely suppress centrosome
maturation [46]. The authors identified a Polo kinase de-
pendent phosphorylation of cnn in mitosis (although they
did not show it was direct), and a co-dependency for cen-
trosomal localisation, similar to that seen for the respective
orthologues CDK5RAP2 and Plk1 in mammals [44,46].
Centrosomin contains two motifs (cnn motifs). Loss of
cnn motif 1 disrupts the ability to rescue lethality of a cnn
knockout and centrosome separation fails, leading to
increased pairs of centrosomes. Centrosomal localisationof D-TACC and g-tubulin is reduced, while another protein,
Mps1, becomes displaced to the centrosome periphery,
suggesting impaired recruitment. This also suggests cnn
motif 1 regulates the assembly of PCM proteins required
for microtubule-organising activity at the centrosome [47].
By contrast, cnn motif 2 disruption does not affect localis-
ation or microtubule organising activity, but causes a
cleavage furrow formation defect in the early Drosophila
embryo [48]. However, as this process is absent from
mammalian development, the relevance for human studies
remains unclear.
Thus, CDK5RAP2 orthologues regulate centrosome
maturation, recruitment to and strengthening of the
PCM at the centrioles, and might also regulate centrosome
cohesion. In their absence, centrosomes fail to mature,
cannot efficiently organise microtubules, and generation
of astral microtubules is reduced., A similar defect in
humans might lead to minor spindle positioning defects
that cannot be tolerated in neuroepithelial progenitors.507
Figure 3. A model suggesting how loss of the MCPH proteins could affect
neurogenesis. Although the MCPH proteins act in diverse pathways, these can be
shown to intersect, resulting in a common mechanism affecting neuron
production. Loss of MCPH1 results in a shorter G1 phase of the cell cycle
through premature mitotic entry, meaning that the centrosomes have not had
sufficient time to mature before the onset of division. Deficiencies in CDK5RAP2 or
CENPJ directly affect centrosome maturation (in the case of CENPJ loss, centrioles
are no longer able to form). Immature centrosomes accumulate less PCM, and are
also less able to generate astral microtubules. This is important because astral
microtubules contact the cell cortex and provide information guiding spindle
orientation during division. By contrast, ASPM and SIL localise specifically to
mitotic spindle poles, where ASPM directly regulates spindle positioning. We
speculate that SIL has a similar role. In apical NE progenitors, spindle positioning
is tightly controlled to ensure bisection of the apical plasma membrane during
symmetric division. By impairing spindle orientation even mildly, loss of any
MCPH protein would lead to an increase in NE cells producing neurogenic progeny
upon division (wide red arrow). The proportion of symmetric divisions is
concomitantly reduced (thin red arrow), depleting the progenitor pool and
limiting the total number of neurons that can be generated.
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The MCPH7 locus and causative mutations in SIL/STIL
were reported during early 2009. mRNA expression was
detected in many tissues, including brain at 16 weeks of
development; while in situ data on the Genepaint website
shows subventricular neuroepithelial expression at
embryonic day 14.5 (E14.5) in mouse [6] (http://www.ge-
nepaint.org).
SIL was previously identified at the site of a genomic
rearrangement in a T-cell acute lymphoblastic leukaemia
(hence the name – SCL Interrupting Locus) [49]. It is an
early response gene and a target of the E2F transcription
factor family; E2F1 and E2F4 have the highest affinity for
the SIL promoter. E2F1 siRNA reduced SIL expression,
leading to delayed transition through mitosis [50,51]. SIL
is hyperphosphorylated in mitosis in a Cdc2 (CDK1)-de-
pendent manner, a modification that promotes interaction
with peptidyl prolyl isomerase (Pin1) and seems to be
required for maintenance of the spindle checkpoint. With-
out SIL (or hyperphosphorylation), the levels of activating
phosphorylation of Cdc2 decrease, lowering the activity of
Cdc2/CyclinB1 and enabling cells to escape the checkpoint
block [52].
The mouse orthologue SIL is expressed in all tissues,
but is highest in bone marrow, thymus and spleen. It is
downregulated upon terminal differentiation in haemato-
poietic and erythroleukaemic mouse cell lines [53]. A
mouse knockout of SIL is embryonic lethal at E10.5.
Between E7.5 and E8.5, the knockout embryos are smaller,
display pericardial swelling, midline neural tube defects,
failure of neural tube closure and holoprosencephaly. A
block in Sonic Hedgehog (Shh) signalling is observed,
which causes a failure in left–right specification. The
numbers of cells in neural folds is reduced compared with
those in wild-type embryos, caused by increased apoptosis
in neural folds and somites [54]. This discrepancy between
human and mouse phenotypes is currently unexplained.
Cassiopeia (csp) is a zebrafish mutant with a loss-of-
function mutation in Sil, and is embryonic lethal.
Increased mitotic cells were seen, with defects including
monopolar spindles, loss of polarity, misaligned chromo-
somes, and broadened spindle poles. g-tubulin staining
suggested that one or both spindle poles were oftenmissing
[55]. Endogenous SIL protein expression could be detected
only in metaphase HeLa cells, where it localised to spindle
poles in a pericentriolar manner, similar to ASPM. No
expression was detected at anaphase. siRNA in HeLa cells
led to an increase in cells with monopolar or unfocussed
poles and disorganised spindles. In the most severe cases,
centrosomes were not localised to spindle poles and dynac-
tin recruitment was lost. The phenotype of csp suggests a
role in spindle organisation, similar to that of ASPM/asp
[55].
In summary, the data so far suggest that SIL has some
similarities with ASPM, although with additional roles in
spindle checkpoint regulation and Hedgehog signalling
pathways. It is tempting to hypothesise that loss of SIL
results in MCPH through a similar spindle pole mechan-
ism. Patients with SIL mutations do not have obvious
developmental defects in Hh signalling so this role might
not be conserved.508Concluding remarks
How close are researchers to understanding, or identifying,
a single pathway that explains how primary microcephaly
proteins regulate brain growth? At first glance, the MCPH
proteins operate in diverse pathways, from transcriptional
regulation (MCPH1, CENPJ and CDK5RAP2), cell-cycle
progression and checkpoint regulation (MCPH1, CENPJ
and CDK5RAP2), centrosome maturation (CDK5RAP2
and CENPJ), DNA repair (MCPH1) to progenitor prolifer-
ation capacity (ASPM and STIL). A case can bemade for all
these pathways affecting neurogenesis; indeed, alterations
of cell-cycle length, spindle positioning or DNA repair
efficiency have been shown to reduce cortical expansion
[26,27,56]. So what is the probable explanation? A direct
interaction between any MCPH proteins to suggest for-
mation of a common complex has not yet been reported.
However, the conserved centrosomal association of all
MCPH proteins is remarkable, and might indicate a role
for the centrosome in coordinating many diverse regulat-
ory pathways. Disruption of all the MCPH proteins can be
shown to either delay centrosome maturation or to disrupt
spindle orientation directly. Delayed centrosome matu-
ration will always affect the daughter centriole and cen-
trosome more than the matured mother centriole and
centrosome, reducing the recruitment of PCM and acces-
sory proteins, and deceasingmicrotubular nucleation. This
yields two unequal centrosomes potentially unable to pos-
ition the spindle symmetrically. Inequality of the mother
and daughter centrosomes in apical neural precursor cells,
Review Trends in Genetics Vol.25 No.11during the early symmetrical cell divisions, might there-
fore provide a common functional link between all MCPH
proteins, as illustrated in Figure 3. We believe that this is
an intriguing hypothesis for future work.
Furthermore, we suggest, as have others, that the
observed disease pathology is a consequence of the sensi-
tivity of apical NE progenitor cells to perturbations, where
inaccuracies tolerated in other tissues have consequences
for fate specification for daughter cells upon division. InNE
progenitors, spindle positioning significantly contributes
to the process guiding the cleavage furrow to the apical
domain. Anything that reduces the fidelity of this process
will lead to a premature shift from symmetrical to asym-
metric cell division, resulting in reduced neuron pro-
duction and a MCPH-like phenotype. The development
of suitable mammalian model systems for neurogenesis
in which to disrupt and study the MCPH proteins will be
crucial to enable these questions to be addressed and
developed further.
Update
While this reviewwas in production, a paper byWang et al.
[78] was published showing that radial glial cells (apical
progenitors, which divide asymmetrically to give one radial
glial cell and one basal progenitor or neuron) partition
their centrosomes asymmetrically between the progeny.
The mature mother centrosome remains with the cell,
which becomes a radial glial cell, while the daughter
centrosome is inherited by the differentiating cell. Preven-
tion of centrosome maturation led to loss of asymmetric
partitioning, a depletion of radial glial cells and an increase
in non-progenitor progeny. Although it is unclear whether
theMCPHproteins affect this process, or the earlier switch
in progenitors from symmetric to asymmetric divisions as
we have hypothesised in this review, Wang et al. confirm
the crucial role of centrosome maturation in affecting cell
fate.
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